| | Presentation | Media | Date |
| Alzecure: CEO Martin Jönsson presents at Redeye Life Science Day 2020
| |
|
December 1, 2020
|
| Scientific presentation on Alzstatin presented at the CTAD conference
|
| |
November 4, 2020
|
| Scientific presentation on the NeuroRestore® candidate ACD856 presented at the CTAD conference
|
| |
November 4, 2020
|
| Scientific and market update with professor Henrik Zetterberg on Alzheimer’s disease, bio-markers, potential future treatments, including Alzstatin and AlzeCure
| |
|
September 30, 2020
|
| AlzeCure presentation with CEO Martin Jönsson at Aktiespararna (Swedish)
| |
|
September 8, 2020
|
| AlzeCure Science & Market update about Alzheimer’s diseas and NeuroRestore (Swedish)
| |
|
September 1, 2020
|
| Scientific presentation about ACD856, a positive modulator of neurotrophin signaling reverses scopolamine- or age-induced cognitive deficits
|
|
|
April 5, 2020
|
| Get to know AlzeCure’s CEO Martin Jönsson – Redeye interview (Swedish)
| |
|
March 19, 2020
|
| AlzeCure presentation with CEO Martin Jönsson at Aktiespararna (Swedish)
| |
|
March 16, 2020
|
